Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2021-2026

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2016-2026
2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region
2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2016-2021)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
2.4.1 For Children (2-10)
2.4.2 For Person (10-64)
2.4.3 For The Old (?65)
2.5 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2016-2021)

3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company
3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2021)
3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2021)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company
3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2021)
3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company
3.4 Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Location Distribution
3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 23-Valent Pneumococcal Polysaccharide Vaccine by Region
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Region
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region
4.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth
4.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth

5 Americas
5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region
6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021)
6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021)
6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Country
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Country
8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type
8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer

11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast
11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Region
11.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2021-2026)
11.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
11.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application

12 Key Players Analysis
12.1 MSD
12.1.1 MSD MSD Company Information
12.1.2 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 MSD Main Business Overview
12.1.5 MSD Latest Developments
12.2 Sanofipasteur
12.2.1 Sanofipasteur Company Information
12.2.2 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sanofipasteur Main Business Overview
12.2.5 Sanofipasteur Latest Developments
12.3 CDIBP
12.3.1 CDIBP Company Information
12.3.2 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CDIBP Main Business Overview
12.3.5 CDIBP Latest Developments
...

13 Research Findings and Conclusion

List of Tables
Table 1. 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Single Dose Vial
Table 3. Major Players of Pre-filled Syringe
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2016-2021)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Application (2016-2021)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2016-2021)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2019-2021) & (K Dose)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Producing Area Distribution and Sales Area
Table 20. Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
Table 21. 23-Valent Pneumococcal Polysaccharide Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) (K Dose)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 29. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2016-2021) & (K Dose)
Table 37. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2016-2021) & (K Dose)
Table 53. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 57. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 59. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026) & (K Dose)
Table 61. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 62. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026) & (K Dose)
Table 65. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 66. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 68. MSD Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 69. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 70. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 71. MSD Main Business
Table 72. MSD Latest Developments
Table 73. Sanofipasteur Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 75. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 76. Sanofipasteur Main Business
Table 77. Sanofipasteur Latest Developments
Table 78. CDIBP Basic Information, 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
Table 80. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 81. CDIBP Main Business
Table 82. CDIBP Latest Developments
List of Figures
Figure 1. Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate 2016-2026 (K Dose)
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Children (2-10)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Children (2-10) (2016-2021) & (K Dose)
Figure 15. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For Person (10-64)
Figure 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For Person (10-64) (2016-2021) & (K Dose)
Figure 17. 23-Valent Pneumococcal Polysaccharide Vaccine Consumed in For The Old (?65)
Figure 18. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market: For The Old (?65) (2016-2021) & (K Dose)
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2020
Figure 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company in 2020
Figure 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 26. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 28. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 30. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales 2016-2021 (K Dose)
Figure 32. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 34. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 36. Americas 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 37. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region in 2020
Figure 42. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 44. APAC 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 45. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 55. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 64. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.